Nav: Home

Study reveals large regional variations on future trends of diabetes dependent on if obesity rates are tackled

October 03, 2018

New research presented at this year's annual meeting of the European Association for the Study of Diabetes (EASD) in Berlin looks into the rising prevalence of both obesity and type 2 diabetes (T2D) around the world and estimates the population that will likely be affected by both conditions over the coming decades.

The research conducted by University College London, Steno Diabetes Centre Copenhagen and Novo Nordisk, studied past trends as a guide to predicting the regional prevalence of obesity and T2D from 2017 to 2045. The study was commissioned by Cities Changing Diabetes, a partnership programme established to improve the understanding of diabetes in urban settings.

Around the world, obesity and T2D are rising at an alarming rate, and while T2D is a complex condition influenced by multiple diverse factors, the one that is most significant, and also modifiable, is excess bodyweight.

There are currently around 650 million obese people around the world, and more than 400 million individuals living with diabetes. In support of the World Health Organization (WHO) Global Target 7* "Halt the rise in diabetes and obesity", the authors have previously demonstrated that stabilising the number of people living with diabetes at 10% of the world's population will require a 25% reduction in the prevalence of obesity. Should this be achieved, a staggering 111 million cases of diabetes would be prevented.

In this study, the team have produced two sets of predictions, one based on a past trend scenario in which rates of obesity and T2D follow existing trends and continue to rise, and another target scenario which assumes that the goal of reducing obesity prevalence by 25% by 2045 is achieved.

The authors obtained BMI data for all the countries in the world covering the years 2000 to 2014 from the Non-communicable Disease Risk Factor Collaboration. The adult population of each country was then split into groups by age and body mass index (BMI), and a projection of the share of people in each BMI class was calculated based on the past trend and the target scenario of reduced obesity. The risk of developing T2D at different ages and BMIs were then applied to the data to estimate diabetes prevalence for each country and scenario in 2045. (for individual country info, please contact the authors details below)

The study found that the North America and Caribbean region has the highest current rates of obesity and T2D (35.7% and 13.2% respectively), and will continue to do so in 2045 in both past trend (51.5% and 16.8%) and target scenario (26.8% and 13.1%) outcomes. If the target scenario can be achieved, it will result in 15.3 million fewer people in the region developing diabetes than if the past trend continues.

Currently the lowest rates of T2D are found in Africa with just 3.3% of the population having the disease, despite a moderate obesity rate of 9.0%. This pattern is projected to continue to 2045 in both past trend (16.4% obesity rate, 4.2% T2D rate), and target (6.4% and 3.5% respectively) scenarios. The authors estimate that 7.2 million people in Africa could avoid acquiring T2D if obesity prevalence can be reduced by 25% by 2045.

In South-East Asia, the pattern is reversed, with the lowest current regional obesity rate of just 4.0% despite a relatively high prevalence of T2D (8.7%). The study suggests that this trend will also continue through to 2045 resulting in past trend (7.9% obesity rate, 12.0% T2D rate) and target (3.1% and 10.7% respectively) scenarios in which achieving the goal of a reduced obesity rate would result in 17.1 million fewer cases of T2D.

The authors note that the proportion of people with T2D who are also obese differs substantially among regions. In North America and the Caribbean 60% of individuals with T2D are obese, while the figure in South-East Asia is just 10%.

The authors say: "North America and the Caribbean and Europe where obesity has been on the rise for decades have the highest T2D prevalence but also the slowest future increases."

They add: "In regions with lower T2D prevalence like Africa, the number of people with T2D will increase up to three-fold in the coming three decades unless obesity prevalence is reduced."

They conclude: "To realise the target scenario, health should be integrated into all policies in order to contribute to reduce the obesity and T2D burden. Not doing so represents a lost opportunity to improve people's health, well-being and economic productivity."


Related Diabetes Articles:

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.
Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
More Diabetes News and Diabetes Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

One of the most consistent questions we get at the show is from parents who want to know which episodes are kid-friendly and which aren't. So today, we're releasing a separate feed, Radiolab for Kids. To kick it off, we're rerunning an all-time favorite episode: Space. In the 60's, space exploration was an American obsession. This hour, we chart the path from romance to increasing cynicism. We begin with Ann Druyan, widow of Carl Sagan, with a story about the Voyager expedition, true love, and a golden record that travels through space. And astrophysicist Neil de Grasse Tyson explains the Coepernican Principle, and just how insignificant we are. Support Radiolab today at